Document Detail


Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome.
MedLine Citation:
PMID:  3876596     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 45-year-old man with primary amyloidosis was initially seen with nephrotic syndrome. Factor X was found to be 5% and antithrombin III (AT III) 45% of normal plasma values. During an 11-month period, despite severe factor X deficiency, the patient did not have any bleeding complications. He developed progressive renal failure and AT III levels increased to normal, at which time he developed severe bleeding complications. These findings suggest a protective role of AT III deficiency against bleeding in a patient with severe factor X deficiency.
Authors:
M Quitt; E Aghai; M David; R Kohan; Y Ben Ari; P Froom
Related Documents :
6976126 - Transhepatic embolization in patients with acute variceal hemorrhage.
1995266 - Demonstration of two distinct subsets of gastric varices. observations during a seven-y...
19580686 - Accurate localization of life threatening colonic hemorrhage during nuclear medicine bl...
19508616 - Prevalence of 'deep' rectal varices in patients with cirrhosis: an eus-based study.
6729646 - Unusual presentation of multiple myeloma. a report of 2 cases.
22038566 - A comprehensive study of autonomic dysfunction in the fibromyalgia patients.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Scandinavian journal of haematology     Volume:  35     ISSN:  0036-553X     ISO Abbreviation:  Scand J Haematol     Publication Date:  1985 Aug 
Date Detail:
Created Date:  1985-11-20     Completed Date:  1985-11-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404507     Medline TA:  Scand J Haematol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  155-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amyloidosis / complications*,  drug therapy
Antithrombin III Deficiency*
Biopsy
Blood Coagulation Tests
Colchicine / therapeutic use
Factor X Deficiency / complications*
Gastrointestinal Hemorrhage / etiology
Humans
Hypoprothrombinemias / complications*
Kidney / pathology
Male
Melphalan / therapeutic use
Middle Aged
Nephrotic Syndrome / complications*
Prednisone / therapeutic use
Splenectomy / adverse effects
Chemical
Reg. No./Substance:
148-82-3/Melphalan; 53-03-2/Prednisone; 64-86-8/Colchicine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement rec...
Next Document:  Zinc deficiency and blood lymphocyte function with sickle cell disease.